BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 17615155)

  • 1. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
    Aragón LM; Garrigó M; Moreno C; Español M; Coll P
    J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey].
    Ozkütük N; Ecemiş T; Sürücüoğlu S
    Mikrobiyol Bul; 2008 Oct; 42(4):585-90. PubMed ID: 19149079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of pyrazinamide resistance in multidrug-resistant tuberculosis cases in Hospital of Pulmonary Diseases, Izmir, Turkey].
    Senol G; Coşkun M; Gündüz AT; Biçmen C; Gayaf M; Ozsöz A
    Mikrobiyol Bul; 2008 Oct; 42(4):591-7. PubMed ID: 19149080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepant results between pyrazinamide susceptibility testing by the reference BACTEC 460TB method and pncA DNA sequencing in patients infected with multidrug-resistant W-Beijing Mycobacterium tuberculosis strains.
    Dormandy J; Somoskovi A; Kreiswirth BN; Driscoll JR; Ashkin D; Salfinger M
    Chest; 2007 Feb; 131(2):497-501. PubMed ID: 17296653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
    Garrigó M; Aragón LM; Alcaide F; Borrell S; Cardeñosa E; Galán JJ; Gonzalez-Martín J; Martin-Casabona N; Moreno C; Salvado M; Coll P
    J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of pyrazinamide susceptibility for Mycobacterium tuberculosis by use of Middlebrook culture media and comparison with results of pyrazinamidase test].
    Yamane N; Nakasone I; Yamashita K; Toyoda K; Okazawa Y
    Rinsho Byori; 1998 May; 46(5):479-85. PubMed ID: 9627500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.
    Yüksel P; Tansel O
    New Microbiol; 2009 Apr; 32(2):153-8. PubMed ID: 19579692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the nitrate-based colorimetric method for testing the susceptibility of Mycobacterium tuberculosis to streptomycin and ethambutol in liquid cultures.
    Syre H; Valvatne H; Sandven P; Grewal HM
    J Antimicrob Chemother; 2006 May; 57(5):987-91. PubMed ID: 16524896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains.
    Sekiguchi J; Nakamura T; Miyoshi-Akiyama T; Kirikae F; Kobayashi I; Augustynowicz-Kopec E; Zwolska Z; Morita K; Suetake T; Yoshida H; Kato S; Mori T; Kirikae T
    J Clin Microbiol; 2007 Sep; 45(9):2802-7. PubMed ID: 17596354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the susceptibility of Mycobacterium tuberculosis to pyrazinamide in liquid and solid media assessed by a colorimetric nitrate reductase assay.
    Syre H; Øvreås K; Grewal HM
    J Antimicrob Chemother; 2010 Apr; 65(4):704-12. PubMed ID: 20118493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system.
    Pfyffer GE; Palicova F; Rüsch-Gerdes S
    J Clin Microbiol; 2002 May; 40(5):1670-4. PubMed ID: 11980940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study of the bacteriophage-based assay for the detection of pyrazinamide resistance in Mycobacterium tuberculosis].
    Ao JP; Chen JW; Hu ZY; Li JN; Wang J; Wang Q; Cui ZL; Zhang WH; Wong XH
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):625-8. PubMed ID: 17129472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a novel kit for use with the BacT/ALERT 3D system for drug susceptibility testing of Mycobacterium tuberculosis.
    Werngren J; Klintz L; Hoffner SE
    J Clin Microbiol; 2006 Jun; 44(6):2130-2. PubMed ID: 16757609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems.
    Tortoli E; Mattei R; Savarino A; Bartolini L; Beer J
    Diagn Microbiol Infect Dis; 2000 Oct; 38(2):83-6. PubMed ID: 11035238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.
    Shenai S; Rodrigues C; Sadani M; Sukhadia N; Mehta A
    Indian J Tuberc; 2009 Apr; 56(2):82-90. PubMed ID: 19810590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to pyrazinamide.
    Ghiraldi LD; Campanerut PA; Spositto FL; Sato DN; Leite CQ; Hirata M; Hirata RD; Cardoso RF
    Clin Microbiol Infect; 2011 Dec; 17(12):1792-7. PubMed ID: 21595790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple fibroblast-based assay to test the pyrazinamide susceptibility of Mycobacterium tuberculosis.
    Takii T; Hamasaki S; Hirano K; Abe C; Onozaki K
    Antimicrob Agents Chemother; 2005 Feb; 49(2):804-7. PubMed ID: 15673774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
    Jonmalung J; Prammananan T; Leechawengwongs M; Chaiprasert A
    BMC Microbiol; 2010 Aug; 10():223. PubMed ID: 20727143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and phenotypic characterization of pyrazinamide-resistant mycobacterium tuberculosis complex isolates in Japan.
    Miyagi C; Yamane N; Yogesh B; Ano H; Takashima T
    Diagn Microbiol Infect Dis; 2004 Feb; 48(2):111-6. PubMed ID: 14972380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].
    Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2010; 78(4):256-62. PubMed ID: 20665445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.